trending Market Intelligence /marketintelligence/en/news-insights/trending/LexsYjnP_CZybUHjYrCTiQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Raymond James upgrades HMS Holdings on revenue growth

Amid Q1 APAC Fintech Funding Slump, Payment Companies Drove Investments

Paypal Well-Positioned To Gain Share In COVID-Related Digital Payments Shift

Digital Banking Battles Will Play Out In Southeast Asias Shopping Cart

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible

Raymond James upgrades HMS Holdings on revenue growth

Raymond James analyst Nicholas Jansen has upgraded healthcare technology company HMS Holdings Corp. to "strong buy" from "outperform," writing that recent selling activity has given the stock more potential to grow.

The company's second-quarter results were obscured by "noise," Jansen wrote, including fallout from an accounting change. But the analyst said the company's 11% sequential core revenue growth "instills confidence" going into the second half of the year.

The analyst also noted that political overhangs for the stock are ending, with attempts in Congress to overhaul, repeal or replace the Affordable Care Act winding down.

Jansen left his price target at $23 per share. His 2017 and 2018 EPS estimates were unchanged at 42 cents and 61 cents, respectively.